{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:07:42Z","timestamp":1792667262062,"version":"4.5.0"},"reference-count":146,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":51,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274538"],"award-info":[{"award-number":["82274538"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Shandong Province Traditional Chinese Medicine Science and Technology Project","award":["Z20243705"],"award-info":[{"award-number":["Z20243705"]}]},{"name":"The Shandong Province Traditional Chinese Medicine Science and Technology Project","award":["MR20243701"],"award-info":[{"award-number":["MR20243701"]}]},{"name":"Tai'an Science and Technology Innovation Development Project","award":["2021NS194"],"award-info":[{"award-number":["2021NS194"]}]},{"name":"Beijing Weiai Public Welfare Foundation Jingyi Medical Research Phase II Research Project","award":["Jv\u21612025-01002 14028"],"award-info":[{"award-number":["Jv\u21612025-01002 14028"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08594-0","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T16:06:26Z","timestamp":1784131586000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The role of ferroptosis in the pathogenesis and treatment of breast cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Ming","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"8594_CR1","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S1535-6108(03)00050-3","volume":"3","author":"S Dolma","year":"2003","unstructured":"Dolma S, Lesnick SL, Hahn WC, et al. Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell. 2003;3:285\u201396.","journal-title":"Cancer Cell"},{"key":"8594_CR2","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.chembiol.2008.02.010","volume":"15","author":"WS Yang","year":"2008","unstructured":"Yang WS, Stockwell BR. Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem Biol. 2008;15:234\u201345.","journal-title":"Chem Biol"},{"key":"8594_CR3","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060\u201372.","journal-title":"Cell"},{"key":"8594_CR4","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.molmed.2020.08.010","volume":"27","author":"M Conrad","year":"2021","unstructured":"Conrad M, Lorenz SM, Pranet B. Targeting ferroptosis: new hope for as-yet-incurable diseases. Trends Mol Med. 2021;27:113\u201322.","journal-title":"Trends Mol Med"},{"key":"8594_CR5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41392-020-00428-9","volume":"6","author":"HF Yan","year":"2021","unstructured":"Yan HF, Zou T, Tuo QZ, et al. Ferroptosis: mechanisms and links with diseases. Signal Transductal Target Ther. 2021;6:49\u201364.","journal-title":"Signal Transductal Target Ther"},{"key":"8594_CR6","doi-asserted-by":"publisher","first-page":"101890","DOI":"10.1016\/j.pneurobio.2020.101890","volume":"196","author":"L Mahoney-S\u00e1nchez","year":"2021","unstructured":"Mahoney-S\u00e1nchez L, Bouchaoui H, Ayton S, et al. Ferroptosis and its potential role in the physiopathology of Parkinson\u2019s disease. Prog Neurobiol. 2021;196:101890.","journal-title":"Prog Neurobiol"},{"key":"8594_CR7","doi-asserted-by":"publisher","first-page":"1038225","DOI":"10.3389\/fimmu.2022.1038225","volume":"13","author":"X Qi","year":"2022","unstructured":"Qi X, Wan Z, Jiang B, et al. Inducing ferroptosis has the potential to overcome therapy resistance in breast cancer[J]. Front Immunol. 2022;13:1038225.","journal-title":"Front Immunol"},{"issue":"1","key":"8594_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41569-022-00735-4","volume":"20","author":"X Fang","year":"2023","unstructured":"Fang X, Ardehali H, Min J, et al. The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease [J]. Nat Rev Cardiol. 2023;20(1):7\u201323.","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"8594_CR9","doi-asserted-by":"publisher","first-page":"180","DOI":"10.7150\/ijbs.64654","volume":"18","author":"B Tang","year":"2022","unstructured":"Tang B, Yan R, Zhu J, et al. Integrative analysis of the molecular mechanisms, immunological features and immunotherapy response of ferroptosis regulators across 33 cancer types. Int J Biol Sci. 2022;18(1):180\u201398.","journal-title":"Int J Biol Sci"},{"issue":"4","key":"8594_CR10","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ccell.2024.03.011","volume":"42","author":"G Lei","year":"2024","unstructured":"Lei G, Zhuang L, Gan B. The roles of ferroptosis in cancer: Tumor suppression, tumor microenvironment, and therapeutic interventions. Cancer Cell. 2024;42(4):513\u201334.","journal-title":"Cancer Cell"},{"issue":"1","key":"8594_CR11","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1038\/s41467-022-29905-1","volume":"13","author":"P Koppula","year":"2022","unstructured":"Koppula P, Lei G, Zhang Y, et al. A targetable CoQ-FSP1 axis drives ferroptosis and radiation resistance in KEAP1 inactive lung cancers [J]. Nat Commun. 2022;13(1):2206.","journal-title":"Nat Commun"},{"issue":"22","key":"8594_CR12","doi-asserted-by":"publisher","first-page":"7038","DOI":"10.1111\/febs.16059","volume":"289","author":"J Liu","year":"2022","unstructured":"Liu J, Kang R, Tang D. Signaling pathways and defense mechanisms of ferroptosis[J]. Febs J. 2022;289(22):7038\u201350.","journal-title":"Febs J"},{"key":"8594_CR13","doi-asserted-by":"publisher","unstructured":"Ding X, Cui L, Mi Y, et al. Ferroptosis in cancer: revealing the multifaceted functions of mitochondria[J]. Cell Mol Life Sci. 2025;82(1). https:\/\/doi.org\/10.1007\/s00018-025-05812-8.","DOI":"10.1007\/s00018-025-05812-8"},{"key":"8594_CR14","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.bbrc.2016.10.086","volume":"482","author":"MM Gaschler","year":"2017","unstructured":"Gaschler MM, Stockwell BR. Lipid peroxidation in cell death. Biochem Biophys Res Commun. 2017;482:419\u201325.","journal-title":"Biochem Biophys Res Commun"},{"key":"8594_CR15","doi-asserted-by":"publisher","first-page":"E4966","DOI":"10.1073\/pnas.1603244113","volume":"113","author":"WS Yang","year":"2016","unstructured":"Yang WS, Kim KJ, Gaschler MM, et al. Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc Natl Acad Sci U S A. 2016;113:E4966\u201375.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8594_CR16","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2021","unstructured":"Tang D, Chen X, Kang R, et al. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2021;31:107\u201325.","journal-title":"Cell Res"},{"key":"8594_CR17","first-page":"184","volume":"10","author":"JY Lee","year":"2021","unstructured":"Lee JY, Kim WK, Bae KH, et al. Lipid metabolism and ferroptosis. Biology (Basel). 2021;10:184.","journal-title":"Biology (Basel)"},{"key":"8594_CR18","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1042\/BJ20111752","volume":"442","author":"A Higdon","year":"2012","unstructured":"Higdon A, Diers AR, Oh JY, et al. Cell signalling by reactive lipid species: new concepts and molecular mechanisms. Biochem J. 2012;442:453\u201364.","journal-title":"Biochem J"},{"key":"8594_CR19","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1111\/cas.13380","volume":"108","author":"R Shintoku","year":"2017","unstructured":"Shintoku R, Takigawa Y, Yamada K, et al. Lipoxygenasemediated generation of lipid peroxides enhances ferroptosis induced by erastin and RSL3. Cancer Sci. 2017;108:2187\u201394.","journal-title":"Cancer Sci"},{"key":"8594_CR20","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.semcdb.2017.05.023","volume":"80","author":"JN Moloney","year":"2018","unstructured":"Moloney JN, Cotter TG. ROS signalling in the biology of cancer. Semin Cell Dev Biol. 2018;80:50\u201364.","journal-title":"Semin Cell Dev Biol"},{"key":"8594_CR21","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1021\/acscentsci.7b00589","volume":"4","author":"R Shah","year":"2018","unstructured":"Shah R, Shchepinov MS, Pratt DA. Resolving the role of lipoxygenases in the initiation and execution of ferroptosis. ACS Cent Sci. 2018;4:387\u201396.","journal-title":"ACS Cent Sci"},{"key":"8594_CR22","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/cdd.2015.158","volume":"23","author":"Y Xie","year":"2016","unstructured":"Xie Y, Hou W, Song X, et al. Ferroptosis: process and function. Cell Death Differ. 2016;23:369\u201379.","journal-title":"Cell Death Differ"},{"key":"8594_CR23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12943-020-01157-x","volume":"19","author":"Y Wu","year":"2020","unstructured":"Wu Y, Zhang S, Gong X, et al. The epigenetic regulators and metabolic changes in ferroptosis-associated cancer progression. Mol Cancer. 2020;19:39\u201355.","journal-title":"Mol Cancer"},{"key":"8594_CR24","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1016\/j.bbagen.2012.11.020","volume":"1830","author":"R Brigelius-Floh\u00e9","year":"2013","unstructured":"Brigelius-Floh\u00e9 R, Maiorino M. Glutathione peroxidases. Biochim Biophys Acta. 2013;1830:3289\u2013303.","journal-title":"Biochim Biophys Acta"},{"key":"8594_CR25","doi-asserted-by":"crossref","unstructured":"Tao N, Li K, Liu J. Molecular mechanisms of ferroptosis and its role in pulmonary disease. Oxid Med Cell Longev. 2020;2020:9547127.","DOI":"10.1155\/2020\/9547127"},{"key":"8594_CR26","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.cmet.2019.09.009","volume":"30","author":"J Zhu","year":"2019","unstructured":"Zhu J, Berisa M, Schw\u00f6rer S, et al. Transsulfuration activity can support cell growth upon extracellular cysteine limitation. Cell Metab. 2019;30:865\u2013e765.","journal-title":"Cell Metab"},{"key":"8594_CR27","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40880-018-0288-x","volume":"38","author":"P Koppula","year":"2018","unstructured":"Koppula P, Zhang Y, Zhuang L, et al. Amino acidtransporter SLC7A11\/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer. Cancer Commun (Lond). 2018;38:12.","journal-title":"Cancer Commun (Lond)"},{"key":"8594_CR28","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00280-008-0894-4","volume":"64","author":"J Guan","year":"2009","unstructured":"Guan J, Lo M, Dockery P, et al. The xc- cystine\/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine. Cancer Chemother Pharmacol. 2009;64:463\u201372.","journal-title":"Cancer Chemother Pharmacol"},{"key":"8594_CR29","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1089\/ars.2017.7134","volume":"27","author":"E Hatem","year":"2017","unstructured":"Hatem E, El Banna N, Huang ME. Multifaceted roles of glutathione and glutathione-based systems in carcinogenesis and anticancer drug resistance. Antioxid Redox Signal. 2017;27:1217\u201334.","journal-title":"Antioxid Redox Signal"},{"key":"8594_CR30","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3390\/cancers12010164","volume":"12","author":"CM Bebber","year":"2020","unstructured":"Bebber CM, M\u00fcller F, Prieto Clemente L, et al. Ferroptosis in cancer cell biology. Cancers (Basel). 2020;12:164.","journal-title":"Cancers (Basel)"},{"key":"8594_CR31","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1007\/s10495-020-01638-w","volume":"25","author":"Y Wang","year":"2020","unstructured":"Wang Y, Wei Z, Pan K, et al. The function and mechanism of ferroptosis in cancer. Apoptosis. 2020;25:786\u201398.","journal-title":"Apoptosis"},{"key":"8594_CR32","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","volume":"575","author":"S Doll","year":"2019","unstructured":"Doll S, Freitas FP, Shah R, et al. FSP1 is a glutathioneindependent ferroptosis suppressor. Nature. 2019;575:693\u20138.","journal-title":"Nature"},{"key":"8594_CR33","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/cac2.12250","volume":"42","author":"L Zhao","year":"2022","unstructured":"Zhao L, Zhou X, Xie F, et al. Ferroptosis in cancer and cancer immunotherapy. Cancer Commun (Lond). 2022;42:88\u2013116.","journal-title":"Cancer Commun (Lond)"},{"key":"8594_CR34","doi-asserted-by":"crossref","unstructured":"Crane FL. Discovery of ubiquinone (coenzyme Q) and an overview of function. Mitochondrion. 2007;7(Suppl):S2\u20137.","DOI":"10.1016\/j.mito.2007.02.011"},{"key":"8594_CR35","doi-asserted-by":"publisher","first-page":"101617","DOI":"10.1016\/j.jbc.2022.101617","volume":"298","author":"NE Mbah","year":"2022","unstructured":"Mbah NE, Lyssiotis CA. Metabolic regulation of ferroptosis in the tumor microenvironment. J Biol Chem. 2022;298:101617.","journal-title":"J Biol Chem"},{"key":"8594_CR36","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/s41589-020-0613-y","volume":"16","author":"M Soula","year":"2020","unstructured":"Soula M, Weber RA, Zilka O, et al. Metabolic determinants of cancer cell sensitivity to canonical ferroptosis inducers. Nat Chem Biol. 2020;16:1351\u201360.","journal-title":"Nat Chem Biol"},{"key":"8594_CR37","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","volume":"593","author":"C Mao","year":"2021","unstructured":"Mao C, Liu X, Zhang Y, et al. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature. 2021;593:586\u201390.","journal-title":"Nature"},{"key":"8594_CR38","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/d41586-021-01203-8","volume":"593","author":"J Garcia-Bermudez","year":"2021","unstructured":"Garcia-Bermudez J, Birsoy K. A mitochondrial gatekeeper that helps cells escape death by ferroptosis. Nature. 2021;593:514\u20135.","journal-title":"Nature"},{"key":"8594_CR39","doi-asserted-by":"publisher","first-page":"101107","DOI":"10.1016\/j.redox.2019.101107","volume":"23","author":"M Dodson","year":"2019","unstructured":"Dodson M, Castro-Portuguez R, Zhang DD. NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol. 2019;23:101107.","journal-title":"Redox Biol"},{"key":"8594_CR40","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41418-019-0380-z","volume":"27","author":"L Wang","year":"2020","unstructured":"Wang L, Liu Y, Du T, et al. ATF3 promotes erastininduced ferroptosis by suppressing system Xc-. Cell Death Differ. 2020;27:662\u201375.","journal-title":"Cell Death Differ"},{"key":"8594_CR41","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature14344","volume":"520","author":"L Jiang","year":"2015","unstructured":"Jiang L, Kon N, Li T, et al. Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 2015;520:57\u201362.","journal-title":"Nature"},{"key":"8594_CR42","doi-asserted-by":"publisher","first-page":"E6806","DOI":"10.1073\/pnas.1607152113","volume":"113","author":"Y Ou","year":"2016","unstructured":"Ou Y, Wang SJ, Li D, et al. Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses. Proc Natl Acad Sci U S A. 2016;113:E6806\u201312.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8594_CR43","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.celrep.2017.12.077","volume":"22","author":"A Tarangelo","year":"2018","unstructured":"Tarangelo A, Magtanong L, Bieging-Rolett KT, et al. P53 suppresses metabolic stress-induced ferroptosis in cancer cells. Cell Rep. 2018;22:569\u201375.","journal-title":"Cell Rep"},{"key":"8594_CR44","doi-asserted-by":"publisher","first-page":"31189","DOI":"10.1073\/pnas.2017152117","volume":"117","author":"J Yi","year":"2020","unstructured":"Yi J, Zhu J, Wu J, et al. Oncogenic activation of PI3KAKT-mTOR signaling suppresses ferroptosis via SREBPmediated lipogenesis. Proc Natl Acad Sci U S A. 2020;117:31189\u201397.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8594_CR45","doi-asserted-by":"publisher","first-page":"672724","DOI":"10.3389\/fonc.2021.672724","volume":"11","author":"J Yang","year":"2021","unstructured":"Yang J, Cao XH, Luan KF, et al. Circular RNA FNDC3B protects oral squamous cell carcinoma cells from ferroptosis and contributes to the malignant progression by regulating miR-520d-5p\/SLC7A11 axis. Front Oncol. 2021;11:672724.","journal-title":"Front Oncol"},{"key":"8594_CR46","doi-asserted-by":"publisher","first-page":"759346","DOI":"10.3389\/fonc.2021.759346","volume":"11","author":"X Lu","year":"2021","unstructured":"Lu X, Kang N, Ling X, et al. MiR-27a-3p promotes nonsmall cell lung cancer through SLC7A11-mediatedferroptosis. Front Oncol. 2021;11:759346.","journal-title":"Front Oncol"},{"key":"8594_CR47","doi-asserted-by":"publisher","first-page":"e2100997","DOI":"10.1002\/advs.202100997","volume":"8","author":"X Yao","year":"2021","unstructured":"Yao X, Li W, Fang D, et al. Emerging roles of energy metabolism in ferroptosis regulation of tumor cells. Adv Sci (Weinh). 2021;8:e2100997.","journal-title":"Adv Sci (Weinh)"},{"key":"8594_CR48","doi-asserted-by":"publisher","first-page":"7179","DOI":"10.1021\/acsnano.1c00380","volume":"15","author":"S Xie","year":"2021","unstructured":"Xie S, Sun W, Zhang C, et al. Metabolic control by heat stress determining cell fate to ferroptosis for effective cancer therapy. ACS Nano. 2021;15:7179\u201394.","journal-title":"ACS Nano"},{"key":"8594_CR49","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrm3311","volume":"13","author":"DG Hardie","year":"2012","unstructured":"Hardie DG, Ross FA, Hawley SA. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol. 2012;13:251\u201362.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8594_CR50","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41556-020-0461-8","volume":"22","author":"H Lee","year":"2020","unstructured":"Lee H, Zandkarimi F, Zhang Y, et al. Energy-stressmediated AMPK activation inhibits ferroptosis. Nat Cell Biol. 2020;22:225\u201334.","journal-title":"Nat Cell Biol"},{"key":"8594_CR51","doi-asserted-by":"publisher","first-page":"1761242","DOI":"10.1080\/23723556.2020.1761242","volume":"7","author":"H Lee","year":"2020","unstructured":"Lee H, Zhuang L, Gan B. Energy stress inhibits ferroptosis via AMPK. Mol Cell Oncol. 2020;7:1761242.","journal-title":"Mol Cell Oncol"},{"key":"8594_CR52","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1016\/j.cub.2018.05.094","volume":"28","author":"X Song","year":"2018","unstructured":"Song X, Zhu S, Chen P, et al. AMPK-mediated BECN1 phosphorylation promotes ferroptosis by directly blocking System Xc\u2013 activity. Curr Biol. 2018;28:2388\u2013e995.","journal-title":"Curr Biol"},{"key":"8594_CR53","doi-asserted-by":"publisher","first-page":"108767","DOI":"10.1016\/j.celrep.2021.108767","volume":"34","author":"X Song","year":"2021","unstructured":"Song X, Liu J, Kuang F, et al. PDK4 dictates metabolic resistance to ferroptosis by suppressing pyruvate oxidation and fatty acid synthesis. Cell Rep. 2021;34:108767.","journal-title":"Cell Rep"},{"key":"8594_CR54","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.3390\/molecules27093011","volume":"27","author":"SL Pandrangi","year":"2022","unstructured":"Pandrangi SL, Chittineedi P, Chalumuri SS, et al. Role of intracellular iron in switching apoptosis to ferroptosis to target therapy-resistant cancer stem cells. Molecules. 2022;27:3011.","journal-title":"Molecules"},{"key":"8594_CR55","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13045-020-00901-6","volume":"13","author":"Y Yang","year":"2020","unstructured":"Yang Y, Li X, Wang T, et al. Emerging agents that target signaling pathways in cancer stem cells. J Hematol Oncol. 2020;13:60.","journal-title":"J Hematol Oncol"},{"key":"8594_CR56","doi-asserted-by":"publisher","first-page":"17667","DOI":"10.1038\/s41598-017-17804-1","volume":"7","author":"C Raggi","year":"2017","unstructured":"Raggi C, Gammella E, Correnti M, et al. Dysregulation of iron metabolism in cholangiocarcinoma stem-like cells. Sci Rep. 2017;7:17667.","journal-title":"Sci Rep"},{"key":"8594_CR57","doi-asserted-by":"publisher","first-page":"11756","DOI":"10.18632\/oncotarget.7598","volume":"7","author":"M Hasegawa","year":"2016","unstructured":"Hasegawa M, Takahashi H, Rajabi H, et al. Functional interactions of the cystine\/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells. Oncotarget. 2016;7:11756\u201369.","journal-title":"Oncotarget"},{"key":"8594_CR58","doi-asserted-by":"publisher","first-page":"778492","DOI":"10.3389\/fonc.2021.778492","volume":"11","author":"Q Guo","year":"2021","unstructured":"Guo Q, Li L, Hou S, et al. The role of iron in cancer progression. Front Oncol. 2021;11:778492.","journal-title":"Front Oncol"},{"issue":"2","key":"8594_CR59","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1021\/acsami.2c19585","volume":"15","author":"S Chen","year":"2023","unstructured":"Chen S, Yang J, Liang Z, et al. Synergistic functional nanomedicine enhances ferroptosis therapy for breast tu- mors by a blocking defensive redox system [J]. ACS Ap- pl Mater Interfaces. 2023;15(2):2705\u201313.","journal-title":"ACS Ap- pl Mater Interfaces"},{"key":"8594_CR60","doi-asserted-by":"publisher","first-page":"538","DOI":"10.3389\/fcell.2020.00538","volume":"8","author":"HJ Liu","year":"2020","unstructured":"Liu HJ, Hu HM, Li GZ, et al. Ferroptosis-related gene signature predicts glioma cell death and glioma patient progression. Front Cell Dev Biol. 2020;8:538.","journal-title":"Front Cell Dev Biol"},{"key":"8594_CR61","doi-asserted-by":"crossref","unstructured":"You Y, Fan Q, Huang J, et al. Ferroptosis-related gene signature promotes ovarian cancer by influencing immune infiltration and invasion. J Oncol. 2021;2021: 9915312.","DOI":"10.1155\/2021\/9915312"},{"key":"8594_CR62","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1002\/cbin.11444","volume":"44","author":"Q Xu","year":"2020","unstructured":"Xu Q, Zhou L, Yang G, et al. CircIL4R facilitates the tumorigenesis and inhibits ferroptosis in hepatocellular carcinoma by regulating the miR-541-3p\/GPX4 axis. Cell Biol Int. 2020;44:2344\u201356.","journal-title":"Cell Biol Int"},{"key":"8594_CR63","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.7150\/jca.65017","volume":"13","author":"N Zhang","year":"2022","unstructured":"Zhang N, Huang J, Xu M, et al. LncRNA T-UCR Uc.339\/miR-339\/SLC7A11 axis regulates the metastasis of ferroptosis-induced lung adenocarcinoma. J Cancer. 2022;13:1945\u201357.","journal-title":"J Cancer"},{"key":"8594_CR64","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","volume":"133","author":"SA Mani","year":"2008","unstructured":"Mani SA, Guo W, Liao MJ, et al. The epithelialmesenchymal transition generates cells with properties of stem cells. Cell. 2008;133:704\u201315.","journal-title":"Cell"},{"key":"8594_CR65","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","volume":"12","author":"Y Mou","year":"2019","unstructured":"Mou Y, Wang J, Wu J, et al. Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol. 2019;12:34.","journal-title":"J Hematol Oncol"},{"key":"8594_CR66","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nrd4253","volume":"13","author":"DR Pattabiraman","year":"2014","unstructured":"Pattabiraman DR, Weinberg RA. Tackling the cancer stem cells- what challenges do they pose? Nat Rev Drug Discov. 2014;13:497\u2013512.","journal-title":"Nat Rev Drug Discov"},{"key":"8594_CR67","doi-asserted-by":"publisher","first-page":"815104","DOI":"10.3389\/fcell.2021.815104","volume":"9","author":"C Shi","year":"2022","unstructured":"Shi C, Xie Y, Li X, et al. Identification of ferroptosisrelated genes signature predicting the efficiency of invasion and metastasis ability in colon adenocarcinoma. Front Cell Dev Biol. 2022;9:815104.","journal-title":"Front Cell Dev Biol"},{"key":"8594_CR68","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/s41586-019-1103-9","volume":"568","author":"FM Behan","year":"2019","unstructured":"Behan FM, Iorio F, Picco G, et al. Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens. Nature. 2019;568:511\u20136.","journal-title":"Nature"},{"key":"8594_CR69","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature24297","volume":"551","author":"MJ Hangauer","year":"2017","unstructured":"Hangauer MJ, Viswanathan VS, Ryan MJ, et al. Drugtolerant persister cancer cells are vulnerable to GPX4 inhibition. Nature. 2017;551:247\u201350.","journal-title":"Nature"},{"key":"8594_CR70","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nature23007","volume":"547","author":"VS Viswanathan","year":"2017","unstructured":"Viswanathan VS, Ryan MJ, Dhruv HD, et al. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature. 2017;547:453\u20137.","journal-title":"Nature"},{"key":"8594_CR71","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41392-020-00216-5","volume":"5","author":"D Li","year":"2020","unstructured":"Li D, Li Y. The interaction between ferroptosis and lipid metabolism in cancer. Signal Transduct Target Ther. 2020;5:108.","journal-title":"Signal Transduct Target Ther"},{"key":"8594_CR72","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41568-019-0149-1","volume":"19","author":"JP Friedmann Angeli","year":"2019","unstructured":"Friedmann Angeli JP, Krysko DV, Conrad M. Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion. Nat Rev Cancer. 2019;19:405\u201314.","journal-title":"Nat Rev Cancer"},{"key":"8594_CR73","doi-asserted-by":"publisher","first-page":"868639","DOI":"10.3389\/fonc.2022.868639","volume":"12","author":"Q Bi","year":"2022","unstructured":"Bi Q, Sun ZJ, Wu JY, et al. Ferroptosis-mediated formation of tumor-promoting immune microenvironment. Front Oncol. 2022;12:868639.","journal-title":"Front Oncol"},{"issue":"4","key":"8594_CR74","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"XJ Jiang","year":"2021","unstructured":"Jiang XJ, Stockwell BR, Conrad M. FeHoptosis: mechanisms, bjology and role jn disease[J]. Nat Rev Mol Cell Bi01. 2021;22(4):266\u201382.","journal-title":"Nat Rev Mol Cell Bi01"},{"issue":"6","key":"8594_CR75","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41568-021-00347-z","volume":"2l","author":"KJ Hiam-GalVez","year":"2021","unstructured":"Hiam-GalVez KJ. A1len BM, Spitzer MH.Systemic immunity in cancer[J]. Nat ReV Cancer. 2021;2l(6):345\u201359.","journal-title":"Nat ReV Cancer"},{"issue":"7","key":"8594_CR76","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41568-019-0149-1","volume":"19","author":"JP Friedmann Angeli","year":"2019","unstructured":"Friedmann Angeli JP, Krysko, Dv. Conrad M.Ferroptosis at the crossroads of cancer-acquired dnlg resistance and immune evasion[J]. Nat Rev Cancer. 2019;19(7):405\u201314.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"8594_CR77","doi-asserted-by":"publisher","first-page":"4758","DOI":"10.1038\/s41467-023-40518-0","volume":"14","author":"Y Xue","year":"2023","unstructured":"Xue Y, Lu FJ, Chang ZZ. et a1.Internlittent dietary methionine depriVation facilitates tumoral ferroptosis and synergizes with checkpointblockade[J]. Nat Commun. 2023;14(1):4758.","journal-title":"Nat Commun"},{"key":"8594_CR78","doi-asserted-by":"crossref","unstructured":"Pena Romero AC, Orenes-Prnero. E. Dual effbct of immune cells within tumour microenvironment: pro-and anti-tumour effects and their triggers[J]. Cancers. 2022;14(7):1681.","DOI":"10.3390\/cancers14071681"},{"issue":"6","key":"8594_CR79","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0092-8674(03)00422-7","volume":"113","author":"K auber","year":"2003","unstructured":"auber K, Bohn E, Krober SM. et a1.Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal[J]. Cell. 2003;113(6):717\u201330.","journal-title":"Cell"},{"issue":"5","key":"8594_CR80","first-page":"825","volume":"2l","author":"VA yurin","year":"2014","unstructured":"yurin VA, Balasubramanian K, Winnica D. et a1.Oxidatively modified phosphatidylserines on the surface of apoptotic cells are essential phagocytic\u2018eat-me\u2019signals: cleavage and inhibition of phagocytosis by lp-PLA2[J]. Cell Death Differ. 2014;2l(5):825\u201335.","journal-title":"Cell Death Differ"},{"key":"8594_CR81","doi-asserted-by":"crossref","unstructured":"He J, Song YJ, Li G, et al. Fbxw7 increases CCL2\/7 in CX3CRlhi macrophages to promote intestinal inflammation [J]. J Clin Invest. 2019;129(9):3877\u201393.","DOI":"10.1172\/JCI123374"},{"issue":"6","key":"8594_CR82","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1038\/s41418-020-00719-2","volume":"28","author":"X Luo","year":"2021","unstructured":"Luo X, Gong HB, Gao HY. et a1. Oxygenated phosphatidylethanolamine navigates phagocytosis of ferroptotic cells by interacting with TLR2[J]. Cell Death Differ. 2021;28(6):1971\u201389.","journal-title":"Cell Death Differ"},{"issue":"1","key":"8594_CR83","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13045-019-0760-3","volume":"12","author":"Y Lin","year":"2019","unstructured":"Lin Y, Xu J, Lan H. Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications. J Hematol Oncol. 2019;12(1):76.","journal-title":"J Hematol Oncol"},{"issue":"3","key":"8594_CR84","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/s41589-019-0462-8","volume":"1 6","author":"AA Kapralov","year":"2020","unstructured":"Kapralov AA, Yang Q, Dar HH, et al. Redox lipid reprogramming commands susceptibility of macrophages and microglia to ferroptotic death[J]. Nat Chem Biol. 2020;1 6(3):278\u201390.","journal-title":"Nat Chem Biol"},{"key":"8594_CR85","doi-asserted-by":"crossref","unstructured":"Ma XZ, Xiao LL, Liu LT, et al. CD36-mediated ferroptosis dampens intratumoral CD8 T cell effector function and impairs their antitumor ability[J]. Cell Metab. 2021;33(5):1001\u201312.","DOI":"10.1016\/j.cmet.2021.02.015"},{"issue":"7","key":"8594_CR86","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.immuni.2021.05.003","volume":"54","author":"S Xu","year":"2021","unstructured":"Xu S, Chaudhary O, Rodr\u00edguez-Morales P, et al. Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8+ T cells in tumors. Immunity. 2021;54(7):1561\u2013e15777.","journal-title":"Immunity"},{"key":"8594_CR87","doi-asserted-by":"crossref","unstructured":"Liao P, Wang WM, Wang WC, et al. CD8 T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4 [J]. Cancer Cell. 2022;40(4):365\u201378.","DOI":"10.1016\/j.ccell.2022.02.003"},{"issue":"3","key":"8594_CR88","doi-asserted-by":"publisher","first-page":"e008554","DOI":"10.1136\/jitc-2023-008554","volume":"12","author":"Q Tao","year":"2024","unstructured":"Tao Q, Liu N, Wu J, et al. Mefloquine enhances the efficacy of anti-PD-1 immunotherapy via IFN-\u03b3-STAT1-IRF1-LPCAT3-induced ferroptosis in tumors. J Immunother Cancer. 2024;12(3):e008554.","journal-title":"J Immunother Cancer"},{"key":"8594_CR89","doi-asserted-by":"crossref","unstructured":"Zhu HB, Klement JD, Lu C, et al. Asah2 represses the p53\u4e00 Hmox 1 axis to protect myeloid\u2014derived suppressor cells from ferroptosis[J]. J Immunol. 2021;206(6):l395\u20131404.","DOI":"10.4049\/jimmunol.2000500"},{"issue":"r7754","key":"8594_CR90","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41586-019-1118-2","volume":"569","author":"F eglia","year":"2019","unstructured":"eglia F, Blasi M. et a1.Fatty acid transport protein 2 reprograms neutrophils in cancer[J]. Nature. 2019;569(r7754):73\u20138.","journal-title":"Nature"},{"issue":"1","key":"8594_CR91","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1158\/0008-5472.CAN-09-2587","volume":"70","author":"MK Srivastava","year":"2010","unstructured":"Srivastava MK, Sinha P, Clements VK, et al. Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine[J]. Cancer Res. 2010;70(1):68\u201377.","journal-title":"Cancer Res"},{"key":"8594_CR92","doi-asserted-by":"crossref","unstructured":"Ugolini A, Tyurin VA, Tyurina YY, et al. Polymorphonuclear myeloid -derived suppressor cells limit antigen cross-presentation by dendritic cells in cancer[J\/OL]. JCI Insight. 2020;5(15): el 3858.","DOI":"10.1172\/jci.insight.138581"},{"issue":"11","key":"8594_CR93","first-page":"109235","volume":"35","author":"CX Xu","year":"2021","unstructured":"Xu CX, Sun SG, Johnson L. a1.The glutathione peroxidase Gpx4 prevents lipid peroxidation and ferroptosis to sustain Treg cell activation and suppression of antitumor immunity[J]. CellRep. 2021;35(11):109235.","journal-title":"CellRep"},{"key":"8594_CR94","doi-asserted-by":"crossref","unstructured":"Wen YY, Li KM, Ni MN. et a1.Dendritic polylysine with paclitaxel and triptolide codelivery for enhanced cancer ferroptosis through the accumulation of ROS[J\/ OL]. ACS Appl Mater Interfaces. 2024 [2024\u201308\u201301].","DOI":"10.1021\/acsami.4c00558"},{"key":"8594_CR95","doi-asserted-by":"crossref","unstructured":"Li S, Ouyang XX, Sun HX, et al. DEPDC5 protects CD8\u2009+\u2009T cells from ferroptosis by limiting mTORC l-mediated purine catabolism[J]. Cell Discov. 2024;10(1):53.","DOI":"10.1038\/s41421-024-00682-z"},{"issue":"3","key":"8594_CR96","doi-asserted-by":"publisher","first-page":"e70253","DOI":"10.1002\/ctm2.70253","volume":"15","author":"X Xia","year":"2025","unstructured":"Xia X, Wu H, Chen Y, et al. Ferroptosis of T cell in inflammation and tumour immunity. Clin Transl Med. 2025;15(3):e70253.","journal-title":"Clin Transl Med"},{"issue":"2","key":"8594_CR97","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41419-022-04579-1","volume":"13","author":"C CHEN","year":"2022","unstructured":"CHEN C, XIE B J. LI Z Q, et a1.Fascin enhances the vulnerability of breast cancer to erastin\u2013induced ferrop- tosis[J]. Cell Death Dis. 2022;13(2):150.","journal-title":"Cell Death Dis"},{"issue":"11","key":"8594_CR98","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1038\/s41388-021-01676-x","volume":"40","author":"CC Lin","year":"2021","unstructured":"Lin CC, Yang WH, Lin YT, et al. DDR2 upregulation confers ferroptosis susceptibility of recurrent breast tumors through the Hippo pathway. Oncogene. 2021;40(11):2018\u201334.","journal-title":"Oncogene"},{"issue":"1","key":"8594_CR99","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1038\/s41467-021-22471-y","volume":"12","author":"A Beatty","year":"2021","unstructured":"Beatty A, Singh T, Tyurina YY, et al. Ferroptotic cell death triggered by conjugated linolenic acids is mediated by ACSL1. Nat Commun. 2021;12(1):2244.","journal-title":"Nat Commun"},{"issue":"21","key":"8594_CR100","doi-asserted-by":"publisher","first-page":"10248","DOI":"10.1111\/jcmm.16963","volume":"25","author":"M Bazhabayi","year":"2021","unstructured":"Bazhabayi M, Qiu X, Li X, et al. CircGFRA1 facilitates the malignant progression of HER-2-positive breast cancer via acting as a sponge of miR-1228 and enhancing AIFM2 expression. J Cell Mol Med. 2021;25(21):10248\u201356.","journal-title":"J Cell Mol Med"},{"issue":"2","key":"8594_CR101","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10549-021-06501-3","volume":"193","author":"SUNB QI L Q","year":"2022","unstructured":"Qi L Q SUNB, Yang B, B. et a1.PGM5P3\u4e00ASl regulates MAPl LC3C to promote cell ferroptosis and thus inhibiting the malignant progression of triple-nega- tive breast cancer[J]. Breast Cancer Res Treat. 2022;193(2):305\u201318.","journal-title":"Breast Cancer Res Treat"},{"key":"8594_CR102","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.canlet.2021.09.033","volume":"522","author":"P YADAV","year":"2021","unstructured":"Yadav P, Sharma P, Sundaram S. et a1. SLC7A1 1\/xCT is a target of miR\u00b7-5096 and its restora-tion partially rescues miR-5096-mediated ferroptosis and anti\u2014tumor effects in human breast cancer cells[J]. Cancer Lett. 2021;522:211\u201324.","journal-title":"Cancer Lett"},{"issue":"1","key":"8594_CR103","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13045-022-01297-1","volume":"15","author":"XIE Y Z","year":"2022","unstructured":"Xie Y Z, Wang B Y. Zhao Y N, et a1.Mammary adipocytes protect triple\u2014negative breast cancer cells from ferroptosis[J]. J Hematol Oncol. 2022;15(1):72.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"8594_CR104","doi-asserted-by":"publisher","first-page":"5103","DOI":"10.1038\/s41467-021-25354-4","volume":"12","author":"W LIU","year":"2021","unstructured":"Liu W, Chakraborty B, Safi R. et a1.Dysreg- ulated cholesterol homeostasis results in resistance to ferroptosis increasing tumorigenicity and metastasis in cancer[J]. Nat Commun. 2021;12(1):5103.","journal-title":"Nat Commun"},{"issue":"1","key":"8594_CR105","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13045-021-01223-x","volume":"15","author":"LI HY, YANG PH. WANG J","year":"2022","unstructured":"Li HY, Yang PH, Wang JH, et al. HLF regulates ferroptosis, development and chemoresistance of triple-negative breast cancer by activating tumor cell-macro- phage crosstalk[J]. J Hematol Oncol. 2022;15(1):2.","journal-title":"J Hematol Oncol"},{"key":"8594_CR106","doi-asserted-by":"crossref","unstructured":"Qi Li H, Liu Y, Jin, et al. Analysis of a new therapeutic target and construction of a prognostic model for breast cancer based on ferroptosis genes[J]. Computers Biology Med. 2023;165(107370):1\u201312.","DOI":"10.1016\/j.compbiomed.2023.107370"},{"issue":"1","key":"8594_CR107","doi-asserted-by":"publisher","first-page":"17610","DOI":"10.1038\/s41598-021-97102-z","volume":"11","author":"Y PENG","year":"2021","unstructured":"Peng Y, Yu H C, Zhang Y Z. al. A ferroptosis-associated gene signature for the prediction of prognosis and therapeutic response in luminal-type breast carcinoma[J]. Sci Rep. 2021;11(1):17610.","journal-title":"Sci Rep"},{"key":"8594_CR108","doi-asserted-by":"publisher","first-page":"895110","DOI":"10.3389\/fimmu.2022.895110","volume":"13","author":"XU Y H","year":"2022","unstructured":"Xu Y H, Du YQ, Zheng Q.H. et al. Identification of ferroptosis\u2014related prognostic signature and subtypes related to the immune microenvironment for breast cancer patients receiving neoadjuvant chemotherapy [. J] Front Immunol. 2022;13:895110.","journal-title":"J] Front Immunol"},{"key":"8594_CR109","doi-asserted-by":"crossref","unstructured":"Sha R, Xu YQ, Yuan CW, et al. Predictive and prognostic impact of ferroptosis\u2014related genes ACSL4 and GPX4 on breast cancer treated with neoadjuvant chemotherapy[J]. EBioMedicine. 2021;71:103560.","DOI":"10.1016\/j.ebiom.2021.103560"},{"issue":"18","key":"8594_CR110","doi-asserted-by":"publisher","first-page":"4576","DOI":"10.3390\/cancers13184576","volume":"13","author":"HY Lin","year":"2021","unstructured":"Lin HY, Ho HW, Chang YH, et al. The evolving role of ferroptosis in breast cancer: Translational implications present and future[J]. Cancers. 2021;13(18):4576.","journal-title":"Cancers"},{"issue":"1","key":"8594_CR111","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13058-019-1177-1","volume":"21","author":"A Nagpal","year":"2019","unstructured":"Nagpal A, Redvers RP, Ling X, et al. Neoadjuvant ne- ratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2\u2009+\u2009ve breast cancer metastasis [J]. Breast Cancer Res. 2019;21(1):94.","journal-title":"Breast Cancer Res"},{"issue":"7","key":"8594_CR112","doi-asserted-by":"publisher","first-page":"e2307","DOI":"10.1038\/cddis.2016.208","volume":"7","author":"S Ma","year":"2016","unstructured":"Ma S, Henson ES, Chen Y, et al. Ferroptosis is in- duced following siramesine and lapatinib treatment of breast cancer cells [J]. Cell Death Dis. 2016;7(7):e2307.","journal-title":"Cell Death Dis"},{"key":"8594_CR113","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.bbrc.2022.06.024","volume":"622","author":"J Liu","year":"2022","unstructured":"Liu J, Sun M, Sun Y, et al. TMEM189 promotes breast cancer through inhibition of autophagy - regulated ferroptosis [J]. Biochem Biophys Res Commun. 2022;622:37\u201344.","journal-title":"Biochem Biophys Res Commun"},{"key":"8594_CR114","doi-asserted-by":"publisher","first-page":"153551","DOI":"10.1016\/j.phymed.2021.153551","volume":"85","author":"J Du","year":"2021","unstructured":"Du J, Wang L, Huang X, et al. Shuganning injection, a traditional Chinese patent medicine, induces ferroptosis and suppresses tumor growth in triple - negative breast cancer cells [J]. Phytomedicine. 2021;85:153551.","journal-title":"Phytomedicine"},{"issue":"1","key":"8594_CR115","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41418-019-0352-3","volume":"27","author":"GQ Chen","year":"2020","unstructured":"Chen GQ, Benthani FA, Wu J, et al. Artemisinin com- pounds sensitize cancer cells to ferroptosis by regulating iron homeostasis [J]. Cell Death Differ. 2020;27(1):242\u201354.","journal-title":"Cell Death Differ"},{"key":"8594_CR116","doi-asserted-by":"crossref","unstructured":"Xu X, Chen Y, Zhang Y, et al. Highly stable and bio- compatible hyaluronic acid-rehabilitated nanoscale MOF- Fe(2+) induced ferroptosis in breast cancer cells [J]. J Mater Chem B. 2020;8(39):9129\u20139138.","DOI":"10.1039\/D0TB01616K"},{"issue":"9","key":"8594_CR117","doi-asserted-by":"publisher","first-page":"6235","DOI":"10.1021\/acs.nanolett.0c00502","volume":"20","author":"J Zhu","year":"2020","unstructured":"Zhu J, Dai P, Liu F, et al. Upconverting nanocarriers enable triggered microtubule inhibition and concurrent ferroptosis induction for selective treatment of triple-neg- ative breast cancer [J]. Nano Lett. 2020;20(9):6235\u201345.","journal-title":"Nano Lett"},{"key":"8594_CR118","doi-asserted-by":"publisher","first-page":"120429","DOI":"10.1016\/j.biomaterials.2020.120429","volume":"266","author":"J Zhang","year":"2021","unstructured":"Zhang J, Yang J, Zuo T, et al. Heparanase - driven se- quential released nanoparticles for ferroptosis and tumor microenvironment modulations synergism in breast can- cer therapy [J]. Biomaterials. 2021;266:120429.","journal-title":"Biomaterials"},{"key":"8594_CR119","doi-asserted-by":"publisher","first-page":"910292","DOI":"10.3389\/fphar.2022.910292","volume":"13","author":"FJ Li","year":"2022","unstructured":"Li FJ, Long HZ, Zhou ZW, et al. System X(c)(-)\/ GSH\/GPX4 axis: An important antioxidant system for the ferroptosis in drug -resistant solid tumor therapy [J]. Front Pharmacol. 2022;13:910292.","journal-title":"Front Pharmacol"},{"key":"8594_CR120","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.3389\/fphar.2019.01226","volume":"10","author":"YS Lin","year":"2019","unstructured":"Lin YS, Shen YC, Wu CY, et al. Danshen improves survival of patients with breast cancer and dihydroisotan- shinone \u2160 induces ferroptosis and apoptosis of breast cancer cells [J]. Front Pharmacol. 2019;10:1226.","journal-title":"Front Pharmacol"},{"issue":"1","key":"8594_CR121","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13045-020-01016-8","volume":"14","author":"Y Ding","year":"2021","unstructured":"Ding Y, Chen X, Liu C, et al. Identification of a small molecule as inducer of ferroptosis and apoptosis through ubiquitination of GPX4 in triple negative breast cancer cells [J]. J Hematol Oncol. 2021;14(1):19.","journal-title":"J Hematol Oncol"},{"key":"8594_CR122","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.freeradbiomed.2021.07.019","volume":"173","author":"Y Wen","year":"2021","unstructured":"Wen Y, Chen H, Zhang L, et al. Glycyrrhetinic acid in- duces oxidative\/nitrative stress and drives ferroptosis through activating NADPH oxidases and iNOS, and de- priving glutathione in triple - negative breast cancer cells [J]. Free Radic Biol Med. 2021;173:41\u201351.","journal-title":"Free Radic Biol Med"},{"key":"8594_CR123","doi-asserted-by":"crossref","unstructured":"Hou Y, Cai S, Yu S, et al. Metformin induces ferropto- sis by targeting miR\u2009\u2013\u2009324-3p\/GPX4 axis in breast cancer [J]. Acta Biochim Biophys Sin (Shanghai). 2021;53 (3):333-3.","DOI":"10.1093\/abbs\/gmaa180"},{"issue":"1","key":"8594_CR124","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1186\/s12951-021-01058-1","volume":"19","author":"X Yao","year":"2021","unstructured":"Yao X, Xie R, Cao Y, et al. Simvastatin induced ferrop- tosis for triple - negative breast cancer therapy [J]. J Nanobiotechnol. 2021;19(1):311.","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"8594_CR125","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13045-021-01223-x","volume":"15","author":"H Li","year":"2022","unstructured":"Li H, Yang P, Wang J, et al. HLF regulates ferropto- sis, development and chemoresistance of triple - negative breast cancer by activating tumor cell-macrophage cross- talk [J]. J Hematol Oncol. 2022;15(1):2.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"8594_CR126","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1038\/s41467-022-30217-7","volume":"13","author":"Y Zou","year":"2022","unstructured":"Zou Y, Zheng S, Xie X, et al. N6-methyladenosine reg- ulated FGFR4 attenuates ferroptotic cell death in recalci- trant HER2 - positive breast cancer [J]. Nat Commun. 2022;13(1):2672.","journal-title":"Nat Commun"},{"key":"8594_CR127","doi-asserted-by":"publisher","first-page":"9921","DOI":"10.1039\/D2SC02597C","volume":"13\u201334\u2013","author":"Y Lai","year":"2022","unstructured":"Lai Y, Lu N, Ouyang A, et al. Ferroptosis promotes so- nodynamic therapy: A platinum(ii)-indocyanine sonosen- sitizer [J]. Chem Sci. 2022;13\u201334\u2013:9921\u20136.","journal-title":"Chem Sci"},{"issue":"22","key":"8594_CR128","doi-asserted-by":"publisher","first-page":"e202202843","DOI":"10.1002\/anie.202202843","volume":"61","author":"Z Zhou","year":"2022","unstructured":"Zhou Z, Liang H, Yang R, et al. Glutathione depletion- induced activation of dimersomes for potentiating the fer- roptosis and immunotherapy of Cold tumor [J]. Angew Chem Int Ed Engl. 2022;61(22):e202202843.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"4","key":"8594_CR129","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.7150\/thno.18005","volume":"7","author":"Y Jiang","year":"2017","unstructured":"Jiang Y, Cao Y, Wang Y, et al. Cysteine transporter SLC3A1 promotes breast cancer tumorigenesis [J]. Theranostics. 2017;7(4):1036\u201346.","journal-title":"Theranostics"},{"issue":"1","key":"8594_CR130","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s13046-021-02012-7","volume":"40","author":"J Yang","year":"2021","unstructured":"Yang J, Zhou Y, Xie S, et al. Metformin induces Fer-roptosis by inhibiting UFMylation of SLC7A11 in breast cancer [J]. J Exp Clin Cancer Res. 2021;40(1):206.","journal-title":"J Exp Clin Cancer Res"},{"key":"8594_CR131","doi-asserted-by":"crossref","unstructured":"Wang J, Li Y, Zhang J, et al. Isoliquiritin modulates fer- roptosis via NF - \u03baB signaling inhibition and alleviates doxorubicin resistance in breast cancer [J]. Immunophar- Macol Immunotoxicol. 2023;1\u201312.","DOI":"10.1080\/08923973.2023.2165943"},{"issue":"7","key":"8594_CR132","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1002\/tox.23509","volume":"37","author":"S Wang","year":"2022","unstructured":"Wang S, Wang Y, Li Q, et al. A novel circular RNA confers trastuzumab resistance in human epidermal growth factor receptor 2 - positive breast cancer through regulating ferroptosis [J]. Environ Toxicol. 2022;37(7):1597\u2013607.","journal-title":"Environ Toxicol"},{"key":"8594_CR133","doi-asserted-by":"crossref","unstructured":"Yang Y, Zhu T, Wang X, et al. ACSL3 and ACSL4, distinct roles in ferroptosis and cancers [J]. Cancers (Ba-sel). 2022;14(23):5896.","DOI":"10.3390\/cancers14235896"},{"key":"8594_CR134","doi-asserted-by":"crossref","unstructured":"Lagrost L, Masson D. The expanding role of lyso-phos- phatidylcholine acyltransferase - 3(LPCAT3), a phos- pholipid remodeling enzyme, in health and disease [J]. Curr Opin Lipidol. 2022;33(3):193\u2013198.","DOI":"10.1097\/MOL.0000000000000820"},{"issue":"2","key":"8594_CR135","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1017\/S0954422421000226","volume":"35","author":"Y Qi","year":"2022","unstructured":"Qi Y, Zhang X, Wu Z, et al. Ferroptosis regulation by nutrient signalling [J]. Nutr Res Rev. 2022;35(2):282\u201394.","journal-title":"Nutr Res Rev"},{"key":"8594_CR136","doi-asserted-by":"publisher","first-page":"103560","DOI":"10.1016\/j.ebiom.2021.103560","volume":"71","author":"R Sha","year":"2021","unstructured":"Sha R, Xu Y, Yuan C, et al. Predictive and prognostic impact of ferroptosis-related genes ACSL4 and GPX4 on breast cancer treated with neoadjuvant chemotherapy [J]. EBioMedicine. 2021;71:103560.","journal-title":"EBioMedicine"},{"issue":"7823","key":"8594_CR137","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41586-020-2623-z","volume":"585","author":"JM Ubellacker","year":"2020","unstructured":"Ubellacker JM, Tasdogan A, Ramesh V, et al. Lymph protects metastasizing melanoma cells from ferroptosis [J]. Nature. 2020;585(7823):113\u20138.","journal-title":"Nature"},{"issue":"20","key":"8594_CR138","doi-asserted-by":"publisher","first-page":"5355","DOI":"10.1158\/0008-5472.CAN-19-0369","volume":"79","author":"L Tesfay","year":"2019","unstructured":"Tesfay L, Paul BT, Konstorum A, et al. Stearoyl-CoA desaturase 1 protects ovarian cancer cells from ferroptotic cell death [J]. Cancer Res. 2019;79(20):5355\u201366.","journal-title":"Cancer Res"},{"key":"8594_CR139","doi-asserted-by":"publisher","first-page":"102006","DOI":"10.1016\/j.redox.2021.102006","volume":"43","author":"G Luis","year":"2021","unstructured":"Luis G, Godfroid A, Nishiumi S, et al. Tumor resis- tance to ferroptosis driven by Stearoyl-CoA Desaturase-1 (SCD1) in cancer cells and Fatty Acid Biding Protein-4 (FABP4) in tumor microenvironment promote tumor re- currence [J]. Redox Biol. 2021;43:102006.","journal-title":"Redox Biol"},{"issue":"8","key":"8594_CR140","doi-asserted-by":"publisher","first-page":"e139434","DOI":"10.1172\/JCI139434","volume":"131","author":"Z Jiang","year":"2021","unstructured":"Jiang Z, Lim SO, Yan M, et al. TYRO3 induces anti- PD-1\/PD-L1 therapy resistance by limiting innate immu- nity and tumoral ferroptosis [J]. J Clin Invest. 2021;131(8):e139434.","journal-title":"J Clin Invest"},{"issue":"1 \u2013 2","key":"8594_CR141","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s11010-020-03821-8","volume":"473","author":"X Wu","year":"2020","unstructured":"Wu X, Liu C, Li Z, et al. Regulation of GSK3\u03b2\/Nrf2 signaling pathway modulated erastin - induced ferroptosis in breast cancer [J]. Mol Cell Biochem. 2020;473(1 \u2013 2):217\u201328.","journal-title":"Mol Cell Biochem"},{"key":"8594_CR142","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.2147\/DDDT.S374328","volume":"16","author":"S Jing","year":"2022","unstructured":"Jing S, Lu Y, Zhang J, et al. Levistilide induces ferrop- tosis by activating the Nrf2\/HO - 1 signaling pathway in breast cancer cells [J]. Drug Des Devel Ther. 2022;16:2981\u201393.","journal-title":"Drug Des Devel Ther"},{"key":"8594_CR143","doi-asserted-by":"crossref","unstructured":"Ohiro Y, Garkavtsev I, Kobayashi S, et al. A novel p53 - inducible apoptogenic gene, PRG3, encodes a homo- logue of the apoptosis-inducing factor (AIF) [J]. FEBS Lett. 2002;524(1\u20133):163\u2013171.","DOI":"10.1016\/S0014-5793(02)03049-1"},{"issue":"7784","key":"8594_CR144","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K Bersuker","year":"2019","unstructured":"Bersuker K, Hendricks JM, Li Z, et al. The CoQ oxido- reductase FSP1 acts parallel to GPX4 to inhibit ferropto- sis [J]. Nature. 2019;575(7784):688\u201392.","journal-title":"Nature"},{"issue":"13","key":"8594_CR145","doi-asserted-by":"publisher","first-page":"e2102799","DOI":"10.1002\/adhm.202102799","volume":"11","author":"J Yang","year":"2022","unstructured":"Yang J, Jia Z, Zhang J, et al. Metabolic intervention nanoparticles for triple-negative breast cancer therapy via overcoming FSP1 - mediated ferroptosis resistance [J]. Adv Healthc Mater. 2022;11(13):e2102799.","journal-title":"Adv Healthc Mater"},{"issue":"7860","key":"8594_CR146","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","volume":"593","author":"C Mao","year":"2021","unstructured":"Mao C, Liu X, Zhang Y, et al. DHODH -mediated fer- roptosis defence is a targetable vulnerability in cancer [J]. Nature. 2021;593(7860):586\u201390.","journal-title":"Nature"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08594-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08594-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08594-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T15:09:12Z","timestamp":1788534552000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08594-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":146,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8594"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08594-0","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"13 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1138"}}